Timmins A C, Hayes M, Yau E, Watson J D, Hinds C J
Department of Anaesthesia and Intensive Care, St Bartholomew's Hospital, London, UK.
Postgrad Med J. 1992;68 Suppl 2:S34-40.
The relationship between survival and cardiac responsiveness to therapy aimed at achieving supranormal values for cardiac index, oxygen delivery and oxygen consumption (cardiac index (CI) > 4.5 l/min/m2, oxygen delivery (DO2) > 600 ml/min/m2, and oxygen consumption (VO2) > 170 ml/min/m2), has been investigated in a heterogeneous group of critically ill patients. Thirty-two patients were prospectively studied and divided into survivors and non-survivors. Cardiac reserve was assessed by determining changes in CI, left ventricular stroke work index (LVSWI) and cardiac power output (CPO) in response to optimal fluid administration and inotropic stimulation with dobutamine. On admission LVSWI and CPO were significantly higher in survivors (P < 0.05), despite no significant differences in pulmonary artery occlusion pressure (PAOP). In response to fluid CI, CPO and LVSWI increased significantly in survivors (P < 0.01), but not in non-survivors. Following optimal fluid administration, survivors achieved significantly higher values for CI, LVSWI (P < 0.01), and CPO (P < 0.001) than non-survivors. At maximum resuscitation all three variables were significantly higher in survivors than in non-survivors (P < 0.001). The dose of dobutamine administered to non-survivors (median (range) 100 (5-200)) was significantly greater (P < 0.001) than that given to the survivors (median (range) 10 (0-25)). The dose of dobutamine was limited by complications in 12 of the non-survivors. These observations suggest that cardiac reserve is an important determinant of outcome following critical illness. In unresponsive patients attempts to achieve supranormal oxygen delivery and consumption with massive inotropic support may not only be ineffective but frequently precipitates tachydysrhythmias and myocardial ischaemia.
针对一组病情各异的重症患者,研究了生存率与心脏对旨在使心脏指数、氧输送和氧消耗达到超常值(心脏指数(CI)>4.5升/分钟/平方米、氧输送(DO2)>600毫升/分钟/平方米、氧消耗(VO2)>170毫升/分钟/平方米)的治疗的反应之间的关系。对32例患者进行了前瞻性研究,并将其分为生存者和非生存者。通过确定CI、左心室每搏功指数(LVSWI)和心脏功率输出(CPO)在最佳液体输注和多巴酚丁胺变力刺激后的变化来评估心脏储备。入院时,尽管肺动脉闭塞压(PAOP)无显著差异,但生存者的LVSWI和CPO显著更高(P<0.05)。在输注液体后,生存者的CI、CPO和LVSWI显著增加(P<0.01),而非生存者则无此变化。在最佳液体输注后,生存者的CI、LVSWI(P<0.01)和CPO(P<0.001)显著高于非生存者。在最大复苏时,所有三个变量在生存者中均显著高于非生存者(P<0.001)。给予非生存者的多巴酚丁胺剂量(中位数(范围)100(5-200))显著高于生存者(中位数(范围)10(0-25))(P<0.001)。12例非生存者因并发症限制了多巴酚丁胺的剂量。这些观察结果表明,心脏储备是重症疾病后预后的重要决定因素。对于无反应的患者,试图通过大量变力支持实现超常的氧输送和消耗不仅可能无效,而且常常会引发快速性心律失常和心肌缺血。